| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 179.155 | 242.293 | 119.354 | 93.786 | 105.905 | 52.522 | 188.055 | 295.446 | 108.033 | 271.629 |
| Venituri Totale - Ron | 203.627 | 244.498 | 119.390 | 93.816 | 105.927 | 52.560 | 208.659 | 295.567 | 109.453 | 271.678 |
| Cheltuieli Totale - Ron | 251.443 | 223.585 | 145.250 | 140.845 | 102.510 | 55.056 | 141.126 | 121.156 | 84.858 | 135.267 |
| Profit/Pierdere Brut - Ron | -47.816 | 20.913 | -25.860 | -47.029 | 3.417 | -2.496 | 67.533 | 174.411 | 24.595 | 136.411 |
| Profit/Pierdere Net - Ron | -47.816 | 13.578 | -29.887 | -49.844 | 238 | -4.072 | 61.397 | 166.873 | 20.925 | 117.626 |
| Salariati | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verifica rapoartele financiare pentru firma - Oncorad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 80.178 | 51.806 | 24.766 | 54 | 26 | 0 | 0 | 0 | 2.917 | 6.817 |
| Active Circulante | 173.589 | 199.833 | 201.594 | 158.505 | 173.173 | 183.736 | 244.117 | 409.252 | 276.813 | 388.752 |
| Stocuri | 114.832 | 114.832 | 114.832 | 114.832 | 131.192 | 131.192 | 114.832 | 114.832 | 114.832 | 114.832 |
| Creante | 20.716 | 13.314 | 65.118 | 11.574 | 12.041 | 19.234 | 12.845 | 6.178 | 6.012 | 6.190 |
| Casa si conturi | 38.041 | 71.687 | 21.644 | 32.099 | 29.940 | 33.310 | 116.440 | 288.242 | 155.969 | 267.730 |
| Capitaluri Proprii | 58.333 | 71.911 | 42.024 | -7.820 | -7.583 | -11.655 | 49.742 | 216.615 | 121.525 | 239.151 |
| Capital Social | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 |
| Datorii | 200.911 | 181.537 | 184.756 | 166.379 | 180.782 | 195.391 | 194.375 | 192.637 | 158.205 | 156.418 |
| Venituri in Avans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "4773 - 4773" | |||||||||
| CAEN An Financiar |
4773
|
|||||||||
Comentarii - Oncorad Med Srl